Common sense breaking out again, but it would be nice to know the terms...
Jan. 11 /PRNewswire/ -- Incyte Genomics, Inc. (Nasdaq: INCY - news) and Gene Logic Inc. (Nasdaq: GLGC - news), announced today a litigation settlement related to patent infringement lawsuits filed by Incyte against Gene Logic in the United States District Court for the Northern District of California alleging infringement of U.S. Patent Numbers 5,716,785, 5,891,636 and 6,023,659. Under the settlement, the lawsuits will be dismissed and Gene Logic will have a non-exclusive license to practice the technology described in these patents. In accordance with the terms of the settlement agreement, specific settlement and financial terms were not disclosed. |
